0USE

Ossiam S&P500 - UCITS ETF 1C (EUR)

ETFs & Funds · EUR · XETRA

0USEETF

Price

€138.66

+0.45%

Cap

Earnings

30d Trend

+6.6%

0USE
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

11% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum67
Technical53
Fund Quality66
Cost Efficiency79

Raw weighted: 70×Macro 0.99 (1%)=69

RISK

15/100
90d Volatility
11.2%Low
ATR %
0.6%Low daily moves
Max Drawdown (1Y)
-7.0%Resilient

MOMENTUM

67/100
12-1M Momentum
+18.6%Strong uptrend
6-1M Momentum
+4.0%Flat
1M Return
+6.1%Strong recent gains

TECHNICAL

53/100
RSI (14)
73.8Overbought
Price vs SMA200
+11.0%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
80%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.552Mixed

FUND QUALITY

66/100
Replication
PhysicalHolds actual assets
Holdings
503 positionsHighly diversified
Domicile
LuxembourgCheck tax treaty
Yield
0.00% (Accumulating)Growth-focused

COST EFFICIENCY

79/100
Expense Ratio
0.07%Ultra-low cost
Fund Size (AUM)
$4.7BMid-size
Tracking Difference
-0.06%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months57
3-12 months72
1-5+ years76

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate Ossiam S&P500 - UCITS ETF 1C (EUR) at 69/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+6.1%

3 MONTHS

+11.3%

12 MONTHS

+24.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Cost Efficiency (79) are the primary strengths. Historical volatility is low at 11%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 69/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.